Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GRM1 | Q13255 | 10/20 | 0.41 |
| ▸ | GRM5 | P41594 | 9/20 | 0.41 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.41 |
| ▸ | ATR | Q13535 | 2/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | WNT3A | P56704 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13985178 | 0.90 | GRM1 (0.45) | GRM1GRM5PDK4ATRCYP11B2 | |
| SCHEMBL4757807 | 0.89 | GRM1 (0.44) | GRM1GRM5PDK4ATRCYP11B2 | |
| Lithium SCHEMBL4757819 | 0.89 | GRM1 (0.44) | GRM1GRM5PDK4ATRCYP11B2 | |
| Lithium Ion SCHEMBL4757812 | 0.88 | GRM1 (0.42) | GRM1GRM5PDK4ATRCYP11B2 | |
| SCHEMBL13985212 | 0.88 | SMN1; SMN2 (0.43) | SMN1; SMN2ENPP2TRPV1 | |
| SCHEMBL28675404 | 0.78 | PDK4 (0.55) | GRM1GRM5PDK4CYP11B2NAMPT | |
| SCHEMBL4757771 | 0.78 | PDK4 (0.45) | GRM1GRM5PDK4CYP11B2NAMPT | |
| SCHEMBL16000811 | 0.75 | TRPV1 (0.55) | GRM1GRM5ATRCYP11B2TRPV1 | |
| SCHEMBL16000812 | 0.75 | TRPV1 (0.54) | GRM1GRM5PDK4ATRNAMPT | |
| SCHEMBL14710349 | 0.75 | NAMPT (0.53) | GRM1GRM5PDK4NAMPTWNT3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009000819-A1 | 5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2008-12-31 | — | — | WO | disclosed |